MINI FUTURE LONG - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME3M6R5

Real-time Bid/Ask 07:34:40 2024-06-20 EDT
4.29 EUR / 4.46 EUR +1.51% Intraday chart for MINI FUTURE LONG - BECTON DICKINSON AND CO.
Current month+4.11%
1 month-7.71%
Date Price Change
24-06-20 4.36 +1.16%
24-06-19 4.31 -2.71%
24-06-18 4.43 +3.02%
24-06-17 4.3 -3.15%
24-06-14 4.44 +3.02%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 06:38 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME3M6R
ISINDE000ME3M6R5
Date issued 2023-11-14
Strike 186.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 5.28
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.32
Lowest since issue 3.32
Spread 0.17
Spread %3.81%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus